Insiders · Profile

Mack Gene

CFO and Interim CEO at Gain Therapeutics. Filing since 9 Aug 2024. CIK 0001737979

Company

Date

Role

Action

Shares

Amount

Of holding

GANX Gain Therapeutics, Inc.

9 Aug 2024

CFO and Interim CEO

Bought

14,400

$14.54K

opened

1 decision on file.